Estrogen modulates inhibitory control in healthy human females: Evidence from the stop-signal paradigm

Neuroscience

Volumn 167, Issue 3, 2010, Pages 709-715

  Colzato, L S ^a   Hertsig, G ^a   van den Wildenberg, W P M ^b   Hommel, B ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Dopamine; Estrogen; Gender differences; Inhibition control; Stop signal task

Indexed keywords

DOPAMINE; ESTRADIOL; ESTROGEN; PROGESTERONE;

ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; HORMONE INHIBITION; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; LUTEAL PHASE; MALE; MENSTRUAL CYCLE; MOTOR PERFORMANCE; NORMAL HUMAN; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; SEX DIFFERENCE; STOP SIGNAL TASK; TASK PERFORMANCE;

ADULT; CORPUS STRIATUM; DOPAMINE; ESTROGENS; FEMALE; FOLLICULAR PHASE; HUMANS; LUTEAL PHASE; MENSTRUATION; NEURAL INHIBITION; NEUROPSYCHOLOGICAL TESTS; PHOTIC STIMULATION; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SEX CHARACTERISTICS; TASK PERFORMANCE AND ANALYSIS; YOUNG ADULT;

EID: 77951270628     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.02.029     Document Type: Article

References (55)

1. Band G.P.H., Van der Molen M.W., Logan G.D. Horse-race model simulations of the stop-signal procedure. Acta Psychol 2003, 112:105-142.
2. Bazzett T.J., Becker J.B. Sex differences in the rapid and acute effects of estrogen on striatal D2 dopamine receptor binding. Brain Res 1994, 637:163-172.
3. Becker J.B. Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol Biochem Behav 1999, 64:803-812.
4. Becker J.B., Molenda H., Hummer D.L. Gender differences in the behavioral responses to cocaine and amphetamine. Implications for mechanisms mediating gender differences in drug abuse. Ann N Y Acad Sci 2001, 937:172-187.
5. Carlsson A., Waters N., Waters S., Carlsson M.L. Network interactions in schizophrenia-therapeutic implications. Brain Res Rev 2000, 31:342-349.
6. Colzato L.S., Huizinga M., Hommel B. Recreational cocaine/polydrug use impairs cognitive flexibility but not working memory. Psychopharmacology 2009, 207:225-234.
7. Colzato L.S., Kool W., Hommel B. Stress modulation of visuomotor binding. Neuropsychologia 2008, 46:1542-1548.
8. Colzato L.S., van den Wildenberg W.P.M., Hommel B. Impaired inhibitory control in recreational cocaine users. PLoS ONE 2007, 2:e1143.
9. Colzato L.S., van den Wildenberg W.P.M., van Wouwe N.C., Pannebakker M.M., Hommel B. Dopamine and inhibitory action control: evidence from spontaneous eye blink rates. Exp Brain Res 2009, 196:467-474.
10. Cools R. Dopaminergic modulation of cognitive function-implication for L-DOPA therapy in Parkinson's disease. Neurosci Biobehav 2006, R30:1-34.
11. Congdon E., Lesch K.P., Canli T. Analysis of DRD4 and DAT polymorphisms and behavioral inhibition in healthy adults: implications for impulsivity. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:27-32.
12. Czoty P.W., Riddick N.V., Gage D.H., Sandridge M., Nader S.H., Garg S., Bounds M., Garg P.K., Nader M.A. Effect of menstrual cycle phase on dopamine D2 receptor availability in female cynomolgus monkeys. Neuropsychopharmacology 2009, 34:548-554.
13. Dazzi L., Seu E., Cherchi G., Barbieri P.P., Matzeu A., Biggio G. Estrus cycle-dependent changes in basal and ethanol-induced activity of cortical dopaminergic neurons in the rat. Neuropsychopharmacology 2007, 32:892-901.
14. Di Paolo T. Modulation of brain dopamine transmission by sex steroids. Rev Neurosci 1994, 5:27-41.
15. Di Paolo T., Falardeau P., Morissette M. Striatal D2 dopamine agonist binding sites fluctuate during the rat estrous cycle. Life Sci 1988, 43:655-672.
16. Di Paolo T., Levesque D., Daigle M. A physiological dose of progesterone affects rat striatum biogenic amine metabolism. Eur J Pharmacol 1986, 125:11-16.
17. Eagle D.M., Tufft M.R., Goodchild H.L., Robbins T.W. Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol. Psychopharmacology 2007, 192:193-206.
18. Elzinga B.M., Roelofs K. Cortisol-induced impairments of working memory require acute sympathetic activation. Behav Neurosci 2005, 119:98-103.
19. Enticott P.G., Ogloff J.R.P., Bradshaw J.L. Response inhibition and impulsivity in schizophrenia. Psychiatry Res 2008, 157:251-254.
20. Evans S.M., Fischman M.W., Folitn R.W. The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology 2002, 159:397-406.
21. Evans S.M., Foltin R.W. Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men. Neuropsychopharmacology 2006, 31:158-167.
22. Fernandez-Ruiz J., Hernandez M.L., de Miguel R., Ramos J.A. Nigrostriatal and mesolimbic dopaminergic activities were modified throughout the ovarian cycle of female rats. J Neural Transm Gen Sect 1991, 85:223-229.
23. Fillmore M.T., Rush C.R. Impaired inhibitory control of behaviour in chronic cocaine users. Drug Alcohol Depend 2002, 66:265-273.
24. Frank M.J., Samanta J., Moustafa A.A., Sherman S.J. Hold your horses: impulsivity, deep brain stimulation and medication in Parkinsonism. Science 2007, 318:1309-1312.
25. Gasbarri A., Pompili A., d'Onofrio A., Cifariello A., Tavares M.C., Tomaz C. Working memory for emotional facial expressions: role of the estrogen in young women. Psychoneuroendocrinology 2008, 33:964-972.
26. Gauggel S., Rieger M., Feghoff T.A. Inhibition of ongoing responses in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2004, 75:539-544.
27. Goldman-Rakic P.S., Muly E.C., Williams G.V. D1 receptors in prefrontal cells and circuits. Brain Res Rev 2000, 31:295-301.
28. Justice A.J., de Wit H. Acute effects of d-amphetamine during the follicular and luteal phase of the menstrual cycle in women. Psychopharmacology 1999, 145:67-75.
29. Kish S., Shannak K., Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. N Engl J Med 1988, 318:876-880.
30. Lecrubier Y., Sheehan D.V., Weiller E., Amorim P., Bonora I., Sheehan K.H. The Mini-International Neuropsychiatric Interview (M.I.N.I.): A short diagnostic structured interview: Reliability and validity according to the CIDI. European Psychiatry 1997, 12:224-231.
31. Leranth C., Roth R.H., Elswoth J.D., Naftolin F., Horvath T.L., Redmond D.E. Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory. J Neurosci 2000, 20:8604-8609.
32. Levitt H.J. Transformed up-down methods in psychoacoustics. J Acoust Soc Am 1971, 49:467-477.
33. Li C.-S.R., Huang C., Constable T., Sinha R. Imaging response inhibition in a stop signal task: neural correlates independent of signal monitoring and post-response processing. J Neurosci 2006, 26:186-192.
34. Lipson S.F., Ellison P.T. Comparison of salivary steroid profiles in naturally occurring conception and non-conception cycles. Hum Reprod 1996, 11:2090-2096.
35. Logan G.D. On the ability to inhibit thought and action: a users' guide to the stop signal paradigm. Inhibitory processes in attention, memory and language 1994, 189-239. Academic Press, San Diego. D. Dagenbach, T.H. Carr (Eds.).
36. Logan G.D., Cowan W.B. On the ability to inhibit thought and action: a theory of an act of control. Psychol Rev 1984, 91:295-327.
37. Lu Y., Benteley G.R., Gann P.H., Hodges K.R., Chatterton R.T. Salivary estradiol and progesterone levels in conception and nonconception cycles in women: evaluation of a new assay for salivary estradiol. Fertil Steril 1999, 71:863-868.
38. Maki P.M., Rich J.B., Rosenbaum R.S. Implicit memory varies across the menstrual cycle: estrogen effects in young women. Neuropsychologia 2002, 40:518-529.
39. McDermott J.L., Liu B., Dluzen D.E. Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice. Exp Neurol 1994, 125:306-311.
40. Mink J.W. The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol 1996, 50:381-425.
41. Miyake A., Friedman N.P., Emerson M.J., Witzki A.H., Howerter A., Wager T. The unity and diversity of executive functions and their contributions to complex "frontal lobe" tasks: A latent variable analysis. Cogn Psychol 2000, 41:49-100.
42. Muly E.C., Szigeti K., Goldman-Rakic P.S. D1 receptor in interneurons of macaque prefrontal cortex: distribution and subcellular localization. J Neurosci 1998, 18:10553-10565.
43. O'Rourke M.T., Ellison P.T. Salivary estradiol levels decrease with age in healthy, regularly-cycling women. Endocr J 1993, 1:487-494.
44. Pazos A., Stoeckel M.E., Hindelang C., Palacios J.M. Autoradiographic studies on dopamine D2 receptors in rat pituitary: influence of hormonal states. Neurosci Lett 1985, 59:1-7.
45. Raven J.C., Court J.H., Raven J. Manual for Raven's progressive matrices and vocabulary scales 1988, Lewis, London.
46. Sofuoglu M., Dudish-Poulsen S., Nelson D., Pentel P.R., Hatsukami D.K. Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. Exp Clin Psychopharmacol 1999, 7:274-283.
47. Szabadi E. Drugs for sleep disorders: mechanisms and therapeutic prospects. Br J Clin Pharmacol 2006, 61:761-766.
48. Terner J.M., de Wit H. Menstrual cycle phase and responses to drugs of abuse in humans. Drug Alcohol Depend 2006, 84:1-13.
49. van den Wildenberg W.P.M., van Boxtel G.J.M., van der Molen M.W., Bosch D.A., Speelman J.D., Brunia C.H.M. Stimulation of the subthalamic region facilitates the selection and inhibition of motor responses in Parkinson's disease. J Cogn Neurosci 2006, 18:626-636.
50. Volkow N.D., Fowler J.S., Wang G.J. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. J Psychopharmacol 1999, 13:337-345.
51. White T.L., Justice A.J., de Wit H. Differential subjective effects of d-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol Biochem Behav 2002, 73:729-741.
52. Williams B., Ponesse J., Schachar R., Logan G.D., Tannock R. Development of inhibitory control across the life span. Dev Psychol 1999, 25:205-213.
53. Wong D.F., Broussolle E.P., Wand G., Villemagne V., Dannals R.F., Links J.M., Zacur H.A., Harris J., Naidu S., Braestrup C., Wagner H.N., Gjedde A. In vivo measurement of dopamine receptors in human brain by positron emission tomography. Age and sex differences. Ann N Y Acad Sci 1988, 515:203-214.
54. Worthman C.M., Stallings J.F., Hofman L.F. Sensitive salivary estradiol assay for monitoring ovarian function. Clin Chem 1990, 36:1769-1773.
55. Wylie SA, Ridderinkhof KR, Bashore TR, van den Wildenberg WPM (in press) The effect of Parkinson's disease on the dynamics of online and proactive cognitive control during action selection. J Cogn Neurosci, in press.